Press News

Press News

Press News | 24.06.2026

 

See here the publicity

 

Web Monitoring Report for the period 23/06 – 24/06

Title Media Publ. Date
Akis Skertsos: And yet, the economy’s productive model is changing amna.gr 23/06/2026
EOPYY: Launches a sweeping audit campaign targeting prescriptions, diagnostic tests, and billing practices by private healthcare providers ethnos.gr 24/06/2026
Stefan Oelrich: Europe must reconsider how it prices new medicines healthdaily.gr 24/06/2026
MoH: New bill to introduce free access to personal health data – What it will mean for prescriptions, hospital stays, and medical examinations healthreport.gr 24/06/2026
HTA Committee at a standstill – Dozens of pharmaceutical dossiers await review as meetings cannot be held healthview.gr 23/06/2026
An additional €200 million by 2029 iatronet.gr 24/06/2026
Europe’s competitive edge in pharmaceutical sector lies in its excellence in basic research and strong production capacity in.gr 24/06/2026
Plasma collection: Why is it important for Europe to have self-sufficiency, and what is Greece’s position? lifo.gr 23/06/2026
D. Giannakopoulos: What the new VIANEX investment in Patras means for the company’s future mononews.gr 24/06/2026
Boukovinas: The future of oncology lies in combination therapies and AI news247.gr 23/06/2026
Eli Lilly: Trump’s pricing policy will affect the launch of obesity medicines in Europe news4health.gr 24/06/2026
HeSMO: Symposium on the health economics of cancer, innovation, access to care, and sustainability news4health.gr 23/06/2026
These medicines were originally designed for other conditions – 3 stories that transformed men’s health protothema.gr 24/06/2026
Clawback: €1.1 billion to be imposed on pharmaceutical companies in 2025 protothema.gr 23/06/2026
Skip to content
SFEE
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.